{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:24:23Z","timestamp":1777400663938,"version":"3.51.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11255-018-1965-z","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T02:23:33Z","timestamp":1534904613000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Vitamin D and calcium kidney stones: a review and a proposal"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7561-3918","authenticated-orcid":false,"given":"Sanaz","family":"Tavasoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-2944","authenticated-orcid":false,"given":"Maryam","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3068365","author":"T Alelign","year":"2018","unstructured":"Alelign T, Petros B (2018) Kidney stone disease: an update on current concepts. Adv Urol \n                    https:\/\/doi.org\/10.1155\/2018\/3068365","journal-title":"Adv Urol"},{"issue":"12","key":"1965_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.eursup.2010.11.006","volume":"9","author":"T Knoll","year":"2010","unstructured":"Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9(12):802\u2013806. \n                    https:\/\/doi.org\/10.1016\/j.eursup.2010.11.006","journal-title":"Eur Urol Suppl"},{"issue":"1","key":"1965_CR3","first-page":"75","volume":"39","author":"MM Hosseini","year":"2014","unstructured":"Hosseini MM, Shakeri S, Manaheji F, Aminsharifi A, Ezatzadegan S, Pakfetrat M, Basiratnia M, Hosseini M (2014) Stone composition in patients who undergo renal stone surgery: review of 423 stone analyses in southern Iran. Iran J Med Sci 39(1):75\u201376","journal-title":"Iran J Med Sci"},{"issue":"4","key":"1965_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00240-010-0349-3","volume":"39","author":"HG Tiselius","year":"2011","unstructured":"Tiselius HG (2011) A hypothesis of calcium stone formation: an interpretation of stone research during the past decades. Urol Res 39(4):231\u2013243. \n                    https:\/\/doi.org\/10.1007\/s00240-010-0349-3","journal-title":"Urol Res"},{"issue":"5","key":"1965_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1053\/j.ajkd.2007.12.030","volume":"51","author":"B West","year":"2008","unstructured":"West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988\u20131994. Am J Kidney Dis 51(5):741\u2013747. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.030","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1965_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/j.ajkd.2012.12.028","volume":"61","author":"Y Kohjimoto","year":"2013","unstructured":"Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61(6):923\u2013929. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2012.12.028","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1965_CR7","first-page":"2391","volume":"12","author":"EC Polat","year":"2015","unstructured":"Polat EC, Ozcan L, Cakir SS, Dursun M, Otunctemur A, Ozbek E (2015) Relationship between calcium stone disease and metabolic syndrome. Urol J 12(6):2391\u20132395","journal-title":"Urol J"},{"issue":"2","key":"1965_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1681\/asn.2013111189","volume":"25","author":"JC Lieske","year":"2014","unstructured":"Lieske JC (2014) New insights regarding the interrelationship of obesity, diet, physical activity, and kidney stones. J Am Soc Nephrol 25(2):211\u2013212. \n                    https:\/\/doi.org\/10.1681\/asn.2013111189","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1965_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00240-011-0448-9","volume":"40","author":"SR Khan","year":"2012","unstructured":"Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40(2):95\u2013112. \n                    https:\/\/doi.org\/10.1007\/s00240-011-0448-9","journal-title":"Urol Res"},{"issue":"11","key":"1965_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","volume":"20","author":"A Mithal","year":"2009","unstructured":"Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, Group IOFCoSANW (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807\u20131820. \n                    https:\/\/doi.org\/10.1007\/s00198-009-0954-6","journal-title":"Osteoporos Int"},{"issue":"4","key":"1965_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477\u2013501. \n                    https:\/\/doi.org\/10.1210\/edrv.22.4.0437","journal-title":"Endocr Rev"},{"issue":"3","key":"1965_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266\u2013281. \n                    https:\/\/doi.org\/10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"issue":"1","key":"1965_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.10.033","volume":"205","author":"J Kendrick","year":"2009","unstructured":"Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205(1):255\u2013260. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.10.033","journal-title":"Atherosclerosis"},{"issue":"5","key":"1965_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4330\/wjc.v6.i5.260","volume":"6","author":"F Carbone","year":"2014","unstructured":"Carbone F, Mach F, Vuilleumier N, Montecucco F (2014) Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J Cardiol 6(5):260\u2013276. \n                    https:\/\/doi.org\/10.4330\/wjc.v6.i5.260","journal-title":"World J Cardiol"},{"key":"1965_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.dsx.2015.02.014","volume":"10","author":"P Prasad","year":"2016","unstructured":"Prasad P, Kochhar A (2016) Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr 10:105\u2013112. \n                    https:\/\/doi.org\/10.1016\/j.dsx.2015.02.014","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"1965_CR16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820\u2013825","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"1965_CR17","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.3390\/nu5103993","volume":"5","author":"M Moukayed","year":"2013","unstructured":"Moukayed M, Grant WB (2013) Molecular link between vitamin D and cancer prevention. Nutrients 5(10):3993\u20134021. \n                    https:\/\/doi.org\/10.3390\/nu5103993","journal-title":"Nutrients"},{"key":"1965_CR18","doi-asserted-by":"publisher","DOI":"10.17226\/13050","volume-title":"Dietary reference Intakes for calcium and vitamin D","author":"IOM (Institute of Medicine)","year":"2011","unstructured":"IOM (Institute of Medicine) (2011) Dietary reference Intakes for calcium and vitamin D. National Academies Press, US, Washington, D. C. \n                    https:\/\/doi.org\/10.17226\/13050"},{"key":"1965_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2014.00335","volume":"5","author":"C Carlberg","year":"2014","unstructured":"Carlberg C (2014) The physiology of vitamin D-far more than calcium and bone. Front Physiol 5:335. \n                    https:\/\/doi.org\/10.3389\/fphys.2014.00335","journal-title":"Front Physiol"},{"issue":"1","key":"1965_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","volume":"47","author":"N Sharifi","year":"2014","unstructured":"Sharifi N, Amani R, Hajiani E, Cheraghian B (2014) Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? a randomized clinical trial. Endocrine 47(1):70\u201380. \n                    https:\/\/doi.org\/10.1007\/s12020-014-0336-5","journal-title":"Endocrine"},{"issue":"4","key":"1965_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MNH.0b013e328360bbcd","volume":"22","author":"J Tang","year":"2013","unstructured":"Tang J, Chonchol MB (2013) Vitamin D and kidney stone disease. Curr Opin Nephrol Hypertens 22(4):383\u2013389. \n                    https:\/\/doi.org\/10.1097\/MNH.0b013e328360bbcd","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1965_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.urology.2011.09.004","volume":"79","author":"MA Elkoushy","year":"2012","unstructured":"Elkoushy MA, Sabbagh R, Unikowsky B, Andonian S (2012) Prevalence and metabolic abnormalities of vitamin D-inadequate patients presenting with urolithiasis to a tertiary stone clinic. Urology 79(4):781\u2013785. \n                    https:\/\/doi.org\/10.1016\/j.urology.2011.09.004","journal-title":"Urology"},{"key":"1965_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00240-016-0954-x","volume":"45","author":"N Johri","year":"2017","unstructured":"Johri N, Jaeger P, Ferraro PM, Shavit L, Nair D, Robertson WG, Gambaro G, Unwin RJ (2017) Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk? Urolithiasis 45:535\u2013543","journal-title":"Urolithiasis"},{"key":"1965_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.urology.2015.10.009","volume":"87","author":"A Ticinesi","year":"2016","unstructured":"Ticinesi A, Nouvenne A, Ferraro PM, Folesani G, Lauretani F, Allegri F, Guerra A, Cerundolo N, Aloe R, Lippi G, Maggio M, Gambaro G, Borghi L, Meschi T (2016) Idiopathic calcium nephrolithiasis and hypovitaminosis D: a case-control study. Urology 87:40\u201345. \n                    https:\/\/doi.org\/10.1016\/j.urology.2015.10.009","journal-title":"Urology"},{"key":"1965_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1290-3","author":"MS Giron-Prieto","year":"2016","unstructured":"Giron-Prieto MS, Del Carmen Cano-Garcia M, Arrabal-Polo MA, Poyatos-Andujar A, Quesada-Charneco M, de Haro-Munoz T, Arias-Santiago S, Arrabal-Martin M (2016) Analysis of vitamin D deficiency in calcium stone-forming patients. Int Urol Nephrol. \n                    https:\/\/doi.org\/10.1007\/s11255-016-1290-3","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"1965_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ando.2015.03.002","volume":"76","author":"P Vestergaard","year":"2015","unstructured":"Vestergaard P (2015) Primary hyperparathyroidism and nephrolithiasis. Ann Endocrinol (Paris) 76(2):116\u2013119. \n                    https:\/\/doi.org\/10.1016\/j.ando.2015.03.002","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"1965_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1042\/cs20040048","volume":"106","author":"JA Sayer","year":"2004","unstructured":"Sayer JA, Carr G, Simmons NL (2004) Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond) 106(6):549\u2013561. \n                    https:\/\/doi.org\/10.1042\/cs20040048","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1965_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ki.2015.76","volume":"88","author":"L Shavit","year":"2015","unstructured":"Shavit L, Jaeger P, Unwin RJ (2015) What is nephrocalcinosis? Kidney Int 88(1):35\u201343. \n                    https:\/\/doi.org\/10.1038\/ki.2015.76","journal-title":"Kidney Int"},{"issue":"6","key":"1965_CR29","doi-asserted-by":"publisher","first-page":"F1243","DOI":"10.1152\/ajprenal.00211.2016","volume":"311","author":"B Oliveira","year":"2016","unstructured":"Oliveira B, Kleta R, Bockenhauer D, Walsh SB (2016) Genetic, pathophysiological, and clinical aspects of nephrocalcinosis. Am J Physiol Renal Physiol 311(6):F1243\u2013Ff1252. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00211.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"1965_CR30","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.juro.2015.05.074","volume":"194","author":"N Bhojani","year":"2015","unstructured":"Bhojani N, Paonessa JE, Hameed TA, Worcester EM, Evan AP, Coe FL, Borofsky MS, Lingeman JE (2015) Nephrocalcinosis in calcium stone formers who do not have systemic disease. J Urol 194(5):1308\u20131312. \n                    https:\/\/doi.org\/10.1016\/j.juro.2015.05.074","journal-title":"J Urol"},{"issue":"11\u201312","key":"1965_CR31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.crci.2016.08.009","volume":"19","author":"M Daudon","year":"2016","unstructured":"Daudon M, Letavernier E, Frochot V, Haymann JP, Bazin D, Jungers P (2016) Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals. C R Chim 19(11\u201312):1504\u20131513. \n                    https:\/\/doi.org\/10.1016\/j.crci.2016.08.009","journal-title":"C R Chim"},{"issue":"2","key":"1965_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1442-2042.2007.01953.x","volume":"15","author":"M Tsujihata","year":"2008","unstructured":"Tsujihata M (2008) Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15(2):115\u2013120. \n                    https:\/\/doi.org\/10.1111\/j.1442-2042.2007.01953.x","journal-title":"Int J Urol"},{"issue":"3","key":"1965_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00240-010-0271-8","volume":"38","author":"FL Coe","year":"2010","unstructured":"Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38(3):147\u2013160. \n                    https:\/\/doi.org\/10.1007\/s00240-010-0271-8","journal-title":"Urol Res"},{"key":"1965_CR34","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG (2016) Kidney stones. Nat Rev Dis Primers 2:16008. \n                    https:\/\/doi.org\/10.1038\/nrdp.2016.8","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1965_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ki.1994.341","volume":"46","author":"DJ Kok","year":"1994","unstructured":"Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46(3):847\u2013854","journal-title":"Kidney Int"},{"issue":"5","key":"1965_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00467-009-1116-y","volume":"25","author":"AP Evan","year":"2010","unstructured":"Evan AP (2010) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25(5):831\u2013841. \n                    https:\/\/doi.org\/10.1007\/s00467-009-1116-y","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"1965_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00240-014-0701-0","volume":"43","author":"AP Evan","year":"2015","unstructured":"Evan AP, Worcester EM, Coe FL, Williams J Jr, Lingeman JE (2015) Mechanisms of human kidney stone formation. Urolithiasis 43(Suppl 1):19\u201332. \n                    https:\/\/doi.org\/10.1007\/s00240-014-0701-0","journal-title":"Urolithiasis"},{"issue":"6","key":"1965_CR38","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1681\/ASN.2006010088","volume":"17","author":"CF Verkoelen","year":"2006","unstructured":"Verkoelen CF (2006) Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? J Am Soc Nephrol 17(6):1673\u20131687. \n                    https:\/\/doi.org\/10.1681\/ASN.2006010088","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1965_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ki.2008.626","volume":"75","author":"K Sakhaee","year":"2009","unstructured":"Sakhaee K (2009) Recent advances in the pathophysiology of nephrolithiasis. Kidney Int 75(6):585\u2013595. \n                    https:\/\/doi.org\/10.1038\/ki.2008.626","journal-title":"Kidney Int"},{"issue":"4","key":"1965_CR40","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1046\/j.1523-1755.2003.00866.x","volume":"63","author":"JH Wiessner","year":"2003","unstructured":"Wiessner JH, Hung LY, Mandel NS (2003) Crystal attachment to injured renal collecting duct cells: influence of urine proteins and pH. Kidney Int 63(4):1313\u20131320. \n                    https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00866.x","journal-title":"Kidney Int"},{"issue":"3","key":"1965_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1464-410X.2006.06334.x","volume":"98","author":"T Umekawa","year":"2006","unstructured":"Umekawa T, Iguchi M, Uemura H, Khan SR (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98(3):656\u2013660. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06334.x","journal-title":"BJU Int"},{"issue":"12","key":"1965_CR42","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1097\/01.ASN.0000099380.18995.F7","volume":"14","author":"M Asselman","year":"2003","unstructured":"Asselman M, Verhulst A, De Broe ME, Verkoelen CF (2003) Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured\/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14(12):3155\u20133166","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1965_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00240-005-0016-2","volume":"34","author":"SR Khan","year":"2006","unstructured":"Khan SR (2006) Renal tubular damage\/dysfunction: key to the formation of kidney stones. Urol Res 34(2):86\u201391. \n                    https:\/\/doi.org\/10.1007\/s00240-005-0016-2","journal-title":"Urol Res"},{"issue":"5","key":"1965_CR44","doi-asserted-by":"publisher","first-page":"F1399","DOI":"10.1152\/ajprenal.00051.2009","volume":"297","author":"V Thamilselvan","year":"2009","unstructured":"Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297(5):F1399\u2013F1410. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00051.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"1965_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12642","author":"V Thamilselvan","year":"2014","unstructured":"Thamilselvan V, Menon M, Thamilselvan S (2014) Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of alpha-tocopherol and ascorbic acid. BJU Int. \n                    https:\/\/doi.org\/10.1111\/bju.12642","journal-title":"BJU Int"},{"issue":"5","key":"1965_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI200317038","volume":"111","author":"AP Evan","year":"2003","unstructured":"Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall\u2019s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111(5):607\u2013616. \n                    https:\/\/doi.org\/10.1172\/JCI200317038","journal-title":"J Clin Invest"},{"issue":"8","key":"1965_CR47","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.ki.5000238","volume":"69","author":"A Evan","year":"2006","unstructured":"Evan A, Lingeman J, Coe FL, Worcester E (2006) Randall\u2019s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69(8):1313\u20131318. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5000238","journal-title":"Kidney Int"},{"issue":"3","key":"1965_CR48","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.078","volume":"189","author":"SR Khan","year":"2013","unstructured":"Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189(3):803\u2013811. \n                    https:\/\/doi.org\/10.1016\/j.juro.2012.05.078","journal-title":"J Urol"},{"issue":"10","key":"1965_CR49","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ar.20580","volume":"290","author":"AP Evan","year":"2007","unstructured":"Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall\u2019s plaque. Anat Rec (Hoboken) 290(10):1315\u20131323. \n                    https:\/\/doi.org\/10.1002\/ar.20580","journal-title":"Anat Rec (Hoboken)"},{"issue":"6","key":"1965_CR50","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1046\/j.1523-1755.2003.00316.x","volume":"64","author":"RL Kuo","year":"2003","unstructured":"Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL (2003) Urine calcium and volume predict coverage of renal papilla by Randall\u2019s plaque. Kidney Int 64(6):2150\u20132154. \n                    https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00316.x","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"1965_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00240-014-0718-4","volume":"43","author":"ER Taylor","year":"2015","unstructured":"Taylor ER, Stoller ML (2015) Vascular theory of the formation of Randall plaques. Urolithiasis 43(Suppl 1):41\u201345. \n                    https:\/\/doi.org\/10.1007\/s00240-014-0718-4","journal-title":"Urolithiasis"},{"issue":"3","key":"1965_CR52","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.juro.2011.10.125","volume":"187","author":"SR Khan","year":"2012","unstructured":"Khan SR, Rodriguez DE, Gower LB, Monga M (2012) Association of Randall plaque with collagen fibers and membrane vesicles. J Urol 187(3):1094\u20131100. \n                    https:\/\/doi.org\/10.1016\/j.juro.2011.10.125","journal-title":"J Urol"},{"issue":"1","key":"1965_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1681\/asn.2015111271","volume":"28","author":"K Taguchi","year":"2017","unstructured":"Taguchi K, Hamamoto S, Okada A, Unno R, Kamisawa H, Naiki T, Ando R, Mizuno K, Kawai N, Tozawa K, Kohri K, Yasui T (2017) Genome-wide gene expression profiling of Randall\u2019s plaques in calcium oxalate stone formers. J Am Soc Nephrol 28(1):333\u2013347. \n                    https:\/\/doi.org\/10.1681\/asn.2015111271","journal-title":"J Am Soc Nephrol"},{"key":"1965_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/462361","author":"S Joshi","year":"2013","unstructured":"Joshi S, Peck AB, Khan SR (2013) NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid Med Cell Longev. \n                    https:\/\/doi.org\/10.1155\/2013\/462361","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1965_CR55","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3978\/j.issn.2223-4683.2014.06.04","volume":"3","author":"SR Khan","year":"2014","unstructured":"Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol 3(3):256\u2013276. \n                    https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2014.06.04","journal-title":"Transl Androl Urol"},{"issue":"1","key":"1965_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00345-015-1563-y","volume":"34","author":"H Tsuji","year":"2016","unstructured":"Tsuji H, Wang W, Sunil J, Shimizu N, Yoshimura K, Uemura H, Peck AB, Khan SR (2016) Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury. World J Urol 34(1):89\u201395. \n                    https:\/\/doi.org\/10.1007\/s00345-015-1563-y","journal-title":"World J Urol"},{"issue":"3","key":"1965_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.ASN.0000113321.49771.2D","volume":"15","author":"T Umekawa","year":"2004","unstructured":"Umekawa T, Hatanaka Y, Kurita T, Khan SR (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15(3):635\u2013644","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"1965_CR58","doi-asserted-by":"publisher","first-page":"13321","DOI":"10.1074\/jbc.M108203200","volume":"277","author":"LS Chaturvedi","year":"2002","unstructured":"Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Menon M, Koul HK (2002) Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 277(15):13321\u201313330. \n                    https:\/\/doi.org\/10.1074\/jbc.M108203200","journal-title":"J Biol Chem"},{"issue":"4","key":"1965_CR59","doi-asserted-by":"publisher","first-page":"C1058","DOI":"10.1152\/ajpcell.00063.2004","volume":"287","author":"HJ Han","year":"2004","unstructured":"Han HJ, Lim MJ, Lee YJ (2004) Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK\/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol 287(4):C1058\u2013C1066. \n                    https:\/\/doi.org\/10.1152\/ajpcell.00063.2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"1965_CR60","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/end.2007.0074","volume":"21","author":"V Tugcu","year":"2007","unstructured":"Tugcu V, Ozbek E, Kemahli E, Cekmen MB, Caner N, Somay A, Erturkuner P, Seckin I, Demir CG, Altug T, Tasci AI (2007) Rapid communication: protective effect of a nuclear factor kappaB inhibitor, pyrolidium dithiocarbamate, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 21(9):1097\u20131106. \n                    https:\/\/doi.org\/10.1089\/end.2007.0074","journal-title":"J Endourol"},{"issue":"1","key":"1965_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1464-410X.2009.08374.x","volume":"104","author":"T Umekawa","year":"2009","unstructured":"Umekawa T, Tsuji H, Uemura H, Khan SR (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 104(1):115\u2013120. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08374.x","journal-title":"BJU Int"},{"issue":"5","key":"1965_CR62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.acuro.2011.08.004","volume":"36","author":"J Carrasco-Valiente","year":"2012","unstructured":"Carrasco-Valiente J, Anglada-Curado FJ, Aguilar-Melero P, Gonzalez-Ojeda R, Muntane-Relat J, Padillo-Ruiz FJ, Requena-Tapia MJ (2012) State of acute phase markers and oxidative stress in patients with kidney stones in the urinary tract. Actas Urol Esp 36(5):296\u2013301. \n                    https:\/\/doi.org\/10.1016\/j.acuro.2011.08.004","journal-title":"Actas Urol Esp"},{"issue":"6","key":"1965_CR63","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0090-4295(03)00764-7","volume":"62","author":"HS Huang","year":"2003","unstructured":"Huang HS, Ma MC, Chen CF, Chen J (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62(6):1123\u20131128","journal-title":"Urology"},{"issue":"5","key":"1965_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00240-014-0676-x","volume":"42","author":"W Kittikowit","year":"2014","unstructured":"Kittikowit W, Waiwijit U, Boonla C, Ruangvejvorachai P, Pimratana C, Predanon C, Ratchanon S, Tosukhowong P (2014) Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis. Urolithiasis 42(5):387\u2013394. \n                    https:\/\/doi.org\/10.1007\/s00240-014-0676-x","journal-title":"Urolithiasis"},{"issue":"5","key":"1965_CR65","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3892\/mmr.2012.813","volume":"5","author":"Z Liu","year":"2012","unstructured":"Liu Z, Wang T, Yang J, Wang S, Yang W, Liu J, Ye Z (2012) Calcium oxalate monohydrate crystals stimulate monocyte chemoattractant protein-1 and transforming growth factor beta1 expression in human renal epithelial cells. Mol Med Rep 5(5):1241\u20131244. \n                    https:\/\/doi.org\/10.3892\/mmr.2012.813","journal-title":"Mol Med Rep"},{"issue":"6","key":"1965_CR66","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/jcla.20215","volume":"21","author":"KC Tsao","year":"2007","unstructured":"Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21(6):426\u2013431. \n                    https:\/\/doi.org\/10.1002\/jcla.20215","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"1965_CR67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00240-007-0098-0","volume":"35","author":"C Boonla","year":"2007","unstructured":"Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35(4):185\u2013191. \n                    https:\/\/doi.org\/10.1007\/s00240-007-0098-0","journal-title":"Urol Res"},{"issue":"2","key":"1965_CR68","doi-asserted-by":"publisher","first-page":"510e519","DOI":"10.1016\/j.urology.2013.09.050","volume":"83","author":"MC Ma","year":"2014","unstructured":"Ma MC, Chen YS, Huang HS (2014) Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage. Urology 83(2):510, e519\u2013e517. \n                    https:\/\/doi.org\/10.1016\/j.urology.2013.09.050","journal-title":"Urology"},{"issue":"4","key":"1965_CR69","doi-asserted-by":"publisher","first-page":"e61343","DOI":"10.1371\/journal.pone.0061343","volume":"8","author":"Y Fujii","year":"2013","unstructured":"Fujii Y, Okada A, Yasui T, Niimi K, Hamamoto S, Hirose M, Kubota Y, Tozawa K, Hayashi Y, Kohri K (2013) Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS ONE 8(4):e61343. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0061343","journal-title":"PLoS ONE"},{"issue":"4","key":"1965_CR70","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1734-1140(13)71078-8","volume":"65","author":"SH Hong","year":"2013","unstructured":"Hong SH, Lee HJ, Sohn EJ, Ko HS, Shim BS, Ahn KS, Kim SH (2013) Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo. Pharmacol Rep 65(4):970\u2013979","journal-title":"Pharmacol Rep"},{"issue":"4","key":"1965_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.ki.5001651","volume":"70","author":"HS Huang","year":"2006","unstructured":"Huang HS, Chen J, Chen CF, Ma MC (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70(4):699\u2013710. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5001651","journal-title":"Kidney Int"},{"issue":"4","key":"1965_CR72","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1248\/bpb.35.539","volume":"35","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Jeong SJ, Park MN, Linnes M, Han HJ, Kim JH, Lieske JC, Kim SH (2012) Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells. Biol Pharm Bull 35(4):539\u2013544","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1965_CR73","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/end.2009.0205","volume":"24","author":"M Davalos","year":"2010","unstructured":"Davalos M, Konno S, Eshghi M, Choudhury M (2010) Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis. J Endourol 24(3):339\u2013345. \n                    https:\/\/doi.org\/10.1089\/end.2009.0205","journal-title":"J Endourol"},{"issue":"12","key":"1965_CR74","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1089\/end.2011.0130","volume":"25","author":"PA Holoch","year":"2011","unstructured":"Holoch PA, Tracy CR (2011) Antioxidants and self-reported history of kidney stones: the National Health and Nutrition Examination Survey. J Endourol 25(12):1903\u20131908. \n                    https:\/\/doi.org\/10.1089\/end.2011.0130","journal-title":"J Endourol"},{"issue":"6 Suppl","key":"1965_CR75","doi-asserted-by":"publisher","first-page":"1689s","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689s\u20131696s","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"1965_CR76","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.mayocp.2013.05.011","volume":"88","author":"A Hossein-nezhad","year":"2013","unstructured":"Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88(7):720\u2013755. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2013.05.011","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"1965_CR77","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1965_CR78","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4065\/mcp.2010.0138","volume":"85","author":"KA Kennel","year":"2010","unstructured":"Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85(8):752\u2013758. \n                    https:\/\/doi.org\/10.4065\/mcp.2010.0138","journal-title":"Mayo Clin Proc"},{"key":"1965_CR79","doi-asserted-by":"publisher","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035. \n                    https:\/\/doi.org\/10.1136\/bmj.g2035","journal-title":"BMJ"},{"issue":"5","key":"1965_CR80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","volume":"175","author":"LA Beveridge","year":"2015","unstructured":"Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, Isbel NM, Larsen T, Nagpal J, Petchey WG, Stricker H, Strobel F, Tangpricha V, Toxqui L, Vaquero MP, Wamberg L, Zittermann A, Witham MD (2015) Effect of Vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 175(5):745\u2013754. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2015.0237","journal-title":"JAMA Intern Med"},{"key":"1965_CR81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.metabol.2017.05.006","volume":"73","author":"C Wu","year":"2017","unstructured":"Wu C, Qiu S, Zhu X, Li L (2017) Vitamin D supplementation and glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Metabolism 73:67\u201376. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2017.05.006","journal-title":"Metabolism"},{"issue":"7","key":"1965_CR82","doi-asserted-by":"publisher","first-page":"e0180512","DOI":"10.1371\/journal.pone.0180512","volume":"12","author":"L Rejnmark","year":"2017","unstructured":"Rejnmark L, Bislev LS, Cashman KD, Eiriksdottir G, Gaksch M, Grubler M, Grimnes G, Gudnason V, Lips P, Pilz S, van Schoor NM, Kiely M, Jorde R (2017) Non-skeletal health effects of vitamin D supplementation: a systematic review on findings from meta-analyses summarizing trial data. PLoS ONE 12(7):e0180512. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0180512","journal-title":"PLoS ONE"},{"key":"1965_CR83","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fphys.2014.00244","volume":"5","author":"TK Wobke","year":"2014","unstructured":"Wobke TK, Sorg BL, Steinhilber D (2014) Vitamin D in inflammatory diseases. Front Physiol 5:244. \n                    https:\/\/doi.org\/10.3389\/fphys.2014.00244","journal-title":"Front Physiol"},{"issue":"5","key":"1965_CR84","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","volume":"188","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E (2012) Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188(5):2127\u20132135. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1102412","journal-title":"J Immunol"},{"issue":"1","key":"1965_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2013.06.004","volume":"437","author":"SK Jain","year":"2013","unstructured":"Jain SK, Micinski D (2013) Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun 437(1):7\u201311. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.004","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1965_CR86","doi-asserted-by":"publisher","first-page":"F647","DOI":"10.1152\/ajprenal.00090.2011","volume":"302","author":"MD Sanchez-Nino","year":"2012","unstructured":"Sanchez-Nino MD, Bozic M, Cordoba-Lanus E, Valcheva P, Gracia O, Ibarz M, Fernandez E, Navarro-Gonzalez JF, Ortiz A, Valdivielso JM (2012) Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 302(6):F647\u2013F657. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00090.2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1965_CR87","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3904\/kjim.2015.224","volume":"31","author":"N Perez-Hernandez","year":"2016","unstructured":"Perez-Hernandez N, Aptilon-Duque G, Nostroza-Hernandez MC, Vargas-Alarcon G, Rodriguez-Perez JM, Blachman-Braun R (2016) Vitamin D and its effects on cardiovascular diseases: a comprehensive review. Korean J Intern Med 31(6):1018\u20131029. \n                    https:\/\/doi.org\/10.3904\/kjim.2015.224","journal-title":"Korean J Intern Med"},{"issue":"41","key":"1965_CR88","doi-asserted-by":"publisher","first-page":"29821","DOI":"10.1074\/jbc.M705495200","volume":"282","author":"W Yuan","year":"2007","unstructured":"Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC (2007) 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282(41):29821\u201329830. \n                    https:\/\/doi.org\/10.1074\/jbc.M705495200","journal-title":"J Biol Chem"},{"issue":"1","key":"1965_CR89","doi-asserted-by":"publisher","first-page":"e54625","DOI":"10.1371\/journal.pone.0054625","volume":"8","author":"S Weng","year":"2013","unstructured":"Weng S, Sprague JE, Oh J, Riek AE, Chin K, Garcia M, Bernal-Mizrachi C (2013) Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS ONE 8(1):e54625. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0054625","journal-title":"PLoS ONE"},{"issue":"12","key":"1965_CR90","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1210\/me.2013-1146","volume":"27","author":"J Kong","year":"2013","unstructured":"Kong J, Zhu X, Shi Y, Liu T, Chen Y, Bhan I, Zhao Q, Thadhani R, Li YC (2013) VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol 27(12):2116\u20132125. \n                    https:\/\/doi.org\/10.1210\/me.2013-1146","journal-title":"Mol Endocrinol"},{"issue":"6","key":"1965_CR91","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40618-015-0414-4","volume":"39","author":"X Deng","year":"2016","unstructured":"Deng X, Cheng J, Shen M (2016) Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress. J Endocrinol Invest 39(6):657\u2013666. \n                    https:\/\/doi.org\/10.1007\/s40618-015-0414-4","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1965_CR92","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12192-013-0474-3","volume":"19","author":"IM Garcia","year":"2014","unstructured":"Garcia IM, Altamirano L, Mazzei L, Fornes M, Cuello-Carrion FD, Ferder L, Manucha W (2014) Vitamin D receptor-modulated Hsp70\/AT1 expression may protect the kidneys of SHRs at the structural and functional levels. Cell Stress Chaperones 19(4):479\u2013491. \n                    https:\/\/doi.org\/10.1007\/s12192-013-0474-3","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"1965_CR93","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1470320312471149","volume":"15","author":"D Carrara","year":"2014","unstructured":"Carrara D, Bernini M, Bacca A, Rugani I, Duranti E, Virdis A, Ghiadoni L, Taddei S, Bernini G (2014) Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst 15(1):82\u201387. \n                    https:\/\/doi.org\/10.1177\/1470320312471149","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"4","key":"1965_CR94","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/bf03347275","volume":"36","author":"G Bernini","year":"2013","unstructured":"Bernini G, Carrara D, Bacca A, Carli V, Virdis A, Rugani I, Duranti E, Ghiadoni L, Bernini M, Taddei S (2013) Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls. J Endocrinol Invest 36(4):216\u2013220. \n                    https:\/\/doi.org\/10.1007\/bf03347275","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1965_CR95","first-page":"93","volume":"54","author":"B Ozkan","year":"2012","unstructured":"Ozkan B, Hatun S, Bereket A (2012) Vitamin D intoxication. Turk J Pediatr 54(2):93\u201398","journal-title":"Turk J Pediatr"},{"issue":"3","key":"1965_CR96","doi-asserted-by":"publisher","first-page":"E301","DOI":"10.3390\/nu9030301","volume":"9","author":"H Hu","year":"2017","unstructured":"Hu H, Zhang J, Lu Y, Zhang Z, Qin B, Gao H, Wang Y, Zhu J, Wang Q, Zhu Y, Xun Y, Wang S (2017) Association between circulating vitamin D level and urolithiasis: a systematic review and meta-analysis. Nutrients 9(3):E301. \n                    https:\/\/doi.org\/10.3390\/nu9030301","journal-title":"Nutrients"},{"issue":"4","key":"1965_CR97","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3945\/ajcn.116.134981","volume":"104","author":"Z Malihi","year":"2016","unstructured":"Malihi Z, Wu Z, Stewart AW, Lawes CM, Scragg R (2016) Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis. Am J Clin Nutr 104(4):1039\u20131051. \n                    https:\/\/doi.org\/10.3945\/ajcn.116.134981","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1965_CR98","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2215\/CJN.11331111","volume":"7","author":"DE Leaf","year":"2012","unstructured":"Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC (2012) Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol 7(5):829\u2013834. \n                    https:\/\/doi.org\/10.2215\/CJN.11331111","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1965_CR99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.juro.2016.10.057","volume":"197","author":"MC Ferroni","year":"2017","unstructured":"Ferroni MC, Rycyna KJ, Averch TD, Semins MJ (2017) Vitamin D repletion in kidney stone formers: a randomized controlled trial. J Urol 197(4):1079\u20131083. \n                    https:\/\/doi.org\/10.1016\/j.juro.2016.10.057","journal-title":"J Urol"},{"issue":"11\u201312","key":"1965_CR100","doi-asserted-by":"publisher","first-page":"E347","DOI":"10.5489\/cuaj.4218","volume":"10","author":"M Dion","year":"2016","unstructured":"Dion M, Ankawi G, Chew B, Paterson R, Sultan N, Hoddinott P, Razvi H (2016) CUA guideline on the evaluation and medical management of the kidney stone patient: 2016 update. Can Urol Assoc J 10(11\u201312):E347\u2013E358. \n                    https:\/\/doi.org\/10.5489\/cuaj.4218","journal-title":"Can Urol Assoc J"},{"issue":"3\u20134","key":"1965_CR101","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000351377","volume":"122","author":"C Pipili","year":"2012","unstructured":"Pipili C, Oreopoulos DG (2012) Vitamin D status in patients with recurrent kidney stones. Nephron Clin Pract 122(3\u20134):134\u2013138. \n                    https:\/\/doi.org\/10.1159\/000351377","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"1965_CR102","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s11255-016-1290-3","volume":"48","author":"MS Gir\u00f3n-prieto","year":"2016","unstructured":"Gir\u00f3n-prieto MS, Del Carmen Cano-garc\u00eda M, Arrabal-polo M, Poyatos-andujar A, Quesada-charneco M, de Haro-Mu\u00f1oz T, Arias-santiago S, Arrabal-mart\u00edn M (2016) Analysis of vitamin D deficiency in calcium stone-forming patients. Int Urol Nephrol 48(8):1243\u20131246. \n                    https:\/\/doi.org\/10.1007\/s11255-016-1290-3","journal-title":"Int Urol Nephrol"},{"key":"1965_CR103","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2458-4-38","volume":"4","author":"S Hashemipour","year":"2004","unstructured":"Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi Z, Fard AR, Hossein-Nezhad A, Booya F (2004) Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 4:38. \n                    https:\/\/doi.org\/10.1186\/1471-2458-4-38","journal-title":"BMC Public Health"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1965-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1965-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1965-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T13:17:38Z","timestamp":1567603058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1965-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1965-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no relevant interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}